| # | Drug | Count |
|---|---|---|
| 0 | ARIPIPRAZOLE | 35 |
| 1 | ARIPIPRAZOLE ORAL | 34 |
| 2 | ARIPIPRAZOLE ORALLY DISINTEGRATING | 34 |
| 3 | OLANZAPINE | 29 |
| 4 | RISPERIDONE | 29 |
| 5 | PREGABALIN | 19 |
| 6 | SERTRALINE | 17 |
| 7 | LAMOTIRIGINE | 16 |
| 8 | LAMOTRIGINE | 16 |
| 9 | LAMOTRIGINE CHEWABLE DISPERSIBLE | 16 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PIMOZIDE | 1 | 0.0021 |
| 1 | HALOPERIDOL DECANOATE | 2 | 0.0011 |
| 2 | AMISULPRIDE | 7 | 0.0011 |
| 3 | CHLORPROMAZINE HYDROCHLORIDE | 1 | 0.0010 |
| 4 | CARIPRAZINE | 8 | 0.0008 |
| 5 | XANOMELINE AND TROSPIUM CHLORIDE | 2 | 0.0007 |
| 6 | HALOPERIDOL LACTATE | 12 | 0.0005 |
| 7 | OLANZAPINE | 29 | 0.0004 |
| 8 | FOSPHENYTOIN SODIUM | 1 | 0.0004 |
| 9 | RISPERIDONE | 29 | 0.0004 |
| # | Drug class | Count |
|---|---|---|
| 0 | Atypical Antipsychotic [EPC] | 57 |
| 1 | Mood Stabilizer [EPC] | 19 |
| 2 | Anti-epileptic Agent [EPC] | 16 |
| 3 | Benzodiazepine [EPC] | 13 |
| 4 | Typical Antipsychotic [EPC] | 13 |
| 5 | Dopamine-2 Receptor Antagonist [EPC] | 7 |
| 6 | Central alpha-2 Adrenergic Agonist [EPC] | 2 |
| 7 | Cholinergic Muscarinic Agonist [EPC] | 2 |
| 8 | Antiarrhythmic [EPC] | 1 |
| 9 | Cholinergic Nicotinic Agonist [EPC] | 1 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Dopamine-2 Receptor Antagonist [EPC] | 7 | 0.0009 |
| 1 | Cholinergic Muscarinic Agonist [EPC] | 2 | 0.0007 |
| 2 | Typical Antipsychotic [EPC] | 13 | 0.0005 |
| 3 | Atypical Antipsychotic [EPC] | 57 | 0.0001 |
| 4 | Sigma-1 Agonist [EPC] | 1 | 0.0001 |
| 5 | Mood Stabilizer [EPC] | 19 | 0.0001 |
| 6 | Anti-epileptic Agent [EPC] | 16 | 0.0001 |
| 7 | Central alpha-2 Adrenergic Agonist [EPC] | 2 | 0.0000 |
| 8 | Provitamin D2 Compound [EPC] | 1 | 0.0000 |
| 9 | Benzodiazepine [EPC] | 13 | 0.0000 |